Ongoing transmission in the Democratic Republic of the Congo drives trader focus, with the Bundibugyo strain outbreak already exceeding 6,000 confirmed cases and nearly 3,000 deaths as of late August 2026, expanding across six provinces amid insecurity and displacement. Neighboring countries face elevated cross-border risk following Uganda’s resolved imported cases and single detections in France and Germany, though sustained local spread remains limited. Vaccination campaigns using Ervebo for frontline workers and enhanced surveillance in at-risk zones represent key near-term catalysts that could contain further international cases through year-end. Traders weigh the outbreak’s rapid growth against response efforts and historical patterns of contained regional transmission.
基於Polymarket數據的AI實驗性摘要。這不是交易建議，也不影響該市場的結算方式。 · 更新於Which countries will have an Ebola case in 2026?
Which countries will have an Ebola case in 2026?
$36,669 交易量
2026-12-31
South Sudan
69%
Rwanda
23%
Burundi
26%
United States
21%
Canada
29%
Kenya
33%
India
14%
Republic of the Congo
24%
Nigeria
44%
Ethiopia
50%
Somalia
36%
China
13%
$36,669 交易量
South Sudan
$3,363 交易量
69%
Rwanda
$2,128 交易量
23%
Burundi
$202 交易量
26%
United States
$10,507 交易量
21%
Canada
$1,534 交易量
29%
Kenya
$235 交易量
33%
India
$732 交易量
14%
Republic of the Congo
$12,281 交易量
24%
Nigeria
$25 交易量
44%
Ethiopia
$107 交易量
50%
Somalia
$71 交易量
36%
China
$3,529 交易量
13%
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.Ongoing transmission in the Democratic Republic of the Congo drives trader focus, with the Bundibugyo strain outbreak already exceeding 6,000 confirmed cases and nearly 3,000 deaths as of late August 2026, expanding across six provinces amid insecurity and displacement. Neighboring countries face elevated cross-border risk following Uganda’s resolved imported cases and single detections in France and Germany, though sustained local spread remains limited. Vaccination campaigns using Ervebo for frontline workers and enhanced surveillance in at-risk zones represent key near-term catalysts that could contain further international cases through year-end. Traders weigh the outbreak’s rapid growth against response efforts and historical patterns of contained regional transmission.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
市場開放時間： May 22, 2026, 12:35 PM ET
交易量
$36,669結束日期
2027-01-01市場開放時間
May 22, 2026, 12:35 PM ETThis market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.Ongoing transmission in the Democratic Republic of the Congo drives trader focus, with the Bundibugyo strain outbreak already exceeding 6,000 confirmed cases and nearly 3,000 deaths as of late August 2026, expanding across six provinces amid insecurity and displacement. Neighboring countries face elevated cross-border risk following Uganda’s resolved imported cases and single detections in France and Germany, though sustained local spread remains limited. Vaccination campaigns using Ervebo for frontline workers and enhanced surveillance in at-risk zones represent key near-term catalysts that could contain further international cases through year-end. Traders weigh the outbreak’s rapid growth against response efforts and historical patterns of contained regional transmission.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
交易量
$36,669結束日期
2027-01-01市場開放時間
May 22, 2026, 12:35 PM ETOngoing transmission in the Democratic Republic of the Congo drives trader focus, with the Bundibugyo strain outbreak already exceeding 6,000 confirmed cases and nearly 3,000 deaths as of late August 2026, expanding across six provinces amid insecurity and displacement. Neighboring countries face elevated cross-border risk following Uganda’s resolved imported cases and single detections in France and Germany, though sustained local spread remains limited. Vaccination campaigns using Ervebo for frontline workers and enhanced surveillance in at-risk zones represent key near-term catalysts that could contain further international cases through year-end. Traders weigh the outbreak’s rapid growth against response efforts and historical patterns of contained regional transmission.
基於Polymarket數據的AI實驗性摘要。這不是交易建議，也不影響該市場的結算方式。 · 更新於
警惕外部連結哦。
警惕外部連結哦。
Frequently Asked Questions